Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

École Polytechnique de Montréal

$19,000.00

Surface engineering of particulates used in the quality control processes of the pharmaceuticals industry (with Mallinckrodt Pharmaceuticals)

EF 2014-15

Résumé
The Canadian pharmaceuticals industry, particularly its sub-sector on the preparation of parenteral (injected) drugs, is highly dependent on both automated and operator-driven visual inspection methods to detect the presence of foreign particulates or other defects. These inspection methods must be regularly validated to ensure appropriate quality control of the final products. As a result of recent significant improvements to the prefilled syringe process at the Mallinckrodt Pharmaceuticals plant in Pointe-Claire (Québec), the 500-um polymer beads used to challenge the visual inspection methods have been found to be too easy to detect. The company would like to challenge its validation processes using either smaller standardized polymer beads (150 um for immediate use, smaller particles to future-proof the process), or actual potential contaminants sampled from the process line. However, such smaller particulates suffer from dispersion issues: when they are placed within challenge syringes, they stick to the syringe walls, thus preventing detection from the motion-based automated sensors. The company has attempted (both in-house and with an outside contractor) to use surfactants to stabilize these challenge particle suspensions, but their efforts have been unsuccessful - the surfactants either have poor shelf life or lead to the stabilization of air bubbles (once again making the challenge syringes too easy to detect). Rather than use surfactants to stabilize the finer challenge particles, we propose a photochemical surface functionalization method (PICVD) developed at École Polytechnique de Montréal. This low-cost, scalable surface engineering method shows great promise to promote stable dispersion of fine particulates, thus providing significant cost savings to the company. The development of stable challenges syringes will be transferrable to a wide range of Canadian pharmaceutical companies, and the synthesis of ""native contaminant"" challenge syringes should prove to be a highly novel contribution to the state of the art.
Programme
Collaborative Research and Development Grants
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
462080-2013
Name nom
Tavares, JasonRobert
Department département
Génie chimique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
19000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Partie
1
Nb partie
2
Application title
Surface engineering of particulates used in the quality control processes of the pharmaceuticals industry (with Mallinckrodt Pharmaceuticals)
Keyword
NSERC
Application summary
The Canadian pharmaceuticals industry, particularly its sub-sector on the preparation of parenteral (injected) drugs, is highly dependent on both automated and operator-driven visual inspection methods to detect the presence of foreign particulates or other defects. These inspection methods must be regularly validated to ensure appropriate quality control of the final products. As a result of recent significant improvements to the prefilled syringe process at the Mallinckrodt Pharmaceuticals plant in Pointe-Claire (Québec), the 500-um polymer beads used to challenge the visual inspection methods have been found to be too easy to detect. The company would like to challenge its validation processes using either smaller standardized polymer beads (150 um for immediate use, smaller particles to future-proof the process), or actual potential contaminants sampled from the process line. However, such smaller particulates suffer from dispersion issues: when they are placed within challenge syringes, they stick to the syringe walls, thus preventing detection from the motion-based automated sensors. The company has attempted (both in-house and with an outside contractor) to use surfactants to stabilize these challenge particle suspensions, but their efforts have been unsuccessful - the surfactants either have poor shelf life or lead to the stabilization of air bubbles (once again making the challenge syringes too easy to detect). Rather than use surfactants to stabilize the finer challenge particles, we propose a photochemical surface functionalization method (PICVD) developed at École Polytechnique de Montréal. This low-cost, scalable surface engineering method shows great promise to promote stable dispersion of fine particulates, thus providing significant cost savings to the company. The development of stable challenges syringes will be transferrable to a wide range of Canadian pharmaceutical companies, and the synthesis of ""native contaminant"" challenge syringes should prove to be a highly novel contribution to the state of the art.